Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Jung, Ji Y ^a   Park, Moo S ^a   Kim, Young S ^a   Park, Byung H ^a   Kim, Se K ^a   Chang, Joon ^a   Kang, Young A ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEPHALOSPORIN; CLINDAMYCIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; COMMUNITY ACQUIRED PNEUMONIA; FEMALE; HEALTHCARE ASSOCIATED PNEUMONIA; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTIOUS PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SOUTH KOREA; TERTIARY HEALTH CARE; TUBE FEEDING; BACTERIAL PNEUMONIA; BACTERIUM; CROSS INFECTION; DRUG EFFECT; HOSPITAL; ISOLATION AND PURIFICATION; MIDDLE AGED;

AGED; ANTI-BACTERIAL AGENTS; BACTERIA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; REPUBLIC OF KOREA;

EID: 79952457542     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-61     Document Type: Article

References (30)

1. Mylotte JM. Nursing home-acquired pneumonia. Clinical Infectious Diseases 2002, 35(10):1205-1211. 10.1086/344281, 12410480.
2. Muder RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. American Journal of Medicine 1998, 105(4):319-330. 10.1016/S0002-9343(98)00262-9, 9809694.
3. Zimmer JG, Hall WJ. Nursing home-acquired pneumonia: avoiding the hospital. Journal of the American Geriatrics Society 1997, 45(3):380-381.
4. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ. Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Annals of Internal Medicine 2002, 137(10):791-797.
5. Brito V, Niederman MS. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Current opinion in infectious diseases 2009, 22(3):316-325. 10.1097/QCO.0b013e328329fa4e, 19352176.
6. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clinical Infectious Diseases 2000, 31(2):383-421. 10.1086/313959, 10987698.
7. Mandell LA, Bartlett JG, Dowell SF, File TM, Musher DM, Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clinical Infectious Diseases 2003, 37(11):1405-1433. 10.1086/380488, 14614663.
8. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. American Journal of Respiratory and Critical Care Medicine 2001, 163(7):1730-1754.
9. American Thoracic Society/Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American Journal of Respiratory and Critical Care Medicine 2005, 171(4):388-416. 10.1164/rccm.200405-644ST, 15699079, American Thoracic Society/Infectious Diseases Society of America.
10. Carratal J, Mykietiuk A, Fernndez-Sab N, Surez C, Dorca J, Verdaguer R, Manresa F, Gudiol F. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Archives of Internal Medicine 2007, 167(13):1393-1399. 10.1001/archinte.167.13.1393, 17620533.
11. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrobial Agents and Chemotherapy 2007, 51(10):3568-3573. 10.1128/AAC.00851-07, 2043297, 17682100.
12. Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Hashimoto N, Imaizumi K, Sato T, Hasegawa Y. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 2009, 135(3):633-640. 10.1378/chest.08-1357, 19017892.
13. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Archives of Internal Medicine 2008, 168(20):2205-2210. 10.1001/archinte.168.20.2205, 19001196.
14. Park HK, Song JU, Um SW, Koh WJ, Suh GY, Chung MP, Kim H, Kwon OJ, Jeon K. Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital. Respiratory Medicine 2010, 104(11):1729-1735. 10.1016/j.rmed.2010.06.009, 20605087.
15. Carratal J, Fernndez-Sab N, Ortega L, Castellsagu X, Rosn B, Dorca J, Fernndez-Agera A, Verdaguer R, Martnez J, Manresa F, Gudiol F. Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Annals of Internal Medicine 2005, 142(3):165-172.
16. Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. American Journal of Respiratory and Critical Care Medicine 1998, 157(2):531-539.
17. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clinical Microbiology Reviews 2001, 14(4):933-951, table of contents. 10.1128/CMR.14.4.933-951.2001, 89009, 11585791.
18. Menndez R, Cavalcanti M, Reyes S, Mensa J, Martinez R, Marcos MA, Filella X, Niederman M, Torres A. Markers of treatment failure in hospitalised community acquired pneumonia. Thorax 2008, 63(5):447-452. 10.1136/thx.2007.086785, 18245147.
19. Rosn B, Carratal J, Fernndez-Sab N, Tubau F, Manresa F, Gudiol F. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Archives of Internal Medicine 2004, 164(5):502-508. 10.1001/archinte.164.5.502, 15006826.
20. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. New England Journal of Medicine 1997, 336(4):243-250. 10.1056/NEJM199701233360402, 8995086.
21. Yandiola PP, Capelastegui A, Quintana J, Diez R, Gorordo I, Bilbao A, Zalacain R, Menendez R, Torres A. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia. Chest 2009, 135(6):1572-1579. 10.1378/chest.08-2179, 19141524.
22. Murray PR, Washington JA. Microscopic and baceriologic analysis of expectorated sputum. Mayo Clinic Proceedings 1975, 50(6):339-344.
23. Clinical and Laboratory Standards Institute Methods for Dilution Antimicrobial Susceptiblity Tests for Bacteria That Grow Aerobically; Approved Standard-Eighth Edition. Clinical and Laboratory Standards Institute 2008, 29(2):M07-A08. Clinical and Laboratory Standards Institute.
24. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005, 128(6):3854-3862. 10.1378/chest.128.6.3854, 16354854.
25. Niederman MS. Making sense of scoring systems in community acquired pneumonia. Respirology 2009, 14(3):327-335. 10.1111/j.1440-1843.2009.01494.x, 19353770.
26. Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Imaizumi K, Hasegawa Y. Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia. Respirology 2008, 13(5):731-735. 10.1111/j.1440-1843.2008.01329.x, 18713094.
27. Shorr AF, Haque N, Taneja C, Zervos M, Lamerato L, Kothari S, Zilber S, Donabedian S, Perri MB, Spalding J, Oster G. Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia. J Clin Microbiol 2010, 48(9):3258-3262. 10.1128/JCM.02529-09, 2937709, 20631118.
28. Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I, Agodi A, Frank U, Mertens K, Schumacher M, Wolkewitz M. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011, 11(1):30-38. 10.1016/S1473-3099(10)70258-9, 21126917.
29. Kothe H, Bauer T, Marre R, Suttorp N, Welte T, Dalhoff K. Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. European Respiratory Journal 2008, 32(1):139-146. 10.1183/09031936.00092507, 18287129.
30. Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J, Torres A. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. American Journal of Respiratory and Critical Care Medicine 1999, 160(2):397-405.